Interpace Biosciences (STU:PF42) E10: €-4.37 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:PF42 Interpace Biosciences Inc STU:PF42
41 GF Score
Price €1.34
GF Value €0.17
! 5 Warning Signs
View Full Analysis

What is Interpace Biosciences E10?

Interpace Biosciences STU:PF42 +0.75% 41 E10 is €-4.37 as of Jun. 2026. GuruFocus rates STU:PF42 with a GF Score™ of 41/100 and a GF Value™ of €0.17. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Interpace Biosciences's adjusted earnings per share data for the three months ended in Jun. 2026 was €0.009. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-4.37 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 34.40% per year. During the past 5 years, the average E10 Growth Rate was 29.00% per year. During the past 10 years, the average E10 Growth Rate was 20.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Interpace Biosciences was 34.40% per year. The lowest was -28.80% per year. And the median was 9.95% per year.

As of today (2026-08-20), Interpace Biosciences's current stock price is €1.34. Interpace Biosciences's E10 for the quarter that ended in Jun. 2026 was €-4.37. Interpace Biosciences's Shiller PE Ratio of today is .


Interpace Biosciences  (STU:PF42) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Interpace Biosciences E10 Related Terms


Interpace Biosciences E10 Historical Data

* Premium members only.

The historical data trend for Interpace Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interpace Biosciences E10 Chart

Interpace Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -47.82 -22.06 -28.93 -17.79 -7.91

Interpace Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.54 -4.83 -7.91 -4.76 -4.37

STU:PF42 vs PRPO, ADVB, BIOQ: E10 Comparison

For the Diagnostics & Research subindustry, Interpace Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interpace Biosciences Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Interpace Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Interpace Biosciences's Shiller PE Ratio falls into.


STU:PF42
41GF Score
Interpace Biosciences Inc STU:PF42
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Interpace Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Interpace Biosciences's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.009/333.9520*333.9520
=0.009

Current CPI (Jun. 2026) = 333.9520.

Interpace Biosciences Quarterly Data

per share eps CPI Adj_EPS
201609 -36.798 241.428 -50.900
201612 30.715 241.432 42.485
201703 5.142 243.801 7.043
201706 -5.785 244.955 -7.887
201709 -1.259 246.819 -1.703
201712 -1.605 246.524 -2.174
201803 -0.892 249.554 -1.194
201806 -0.599 251.989 -0.794
201809 -0.943 252.439 -1.247
201812 -1.231 251.233 -1.636
201903 -0.832 254.202 -1.093
201906 -1.230 256.143 -1.604
201909 -1.789 256.759 -2.327
201912 -2.601 256.974 -3.380
202003 -2.154 258.115 -2.787
202006 -1.225 257.797 -1.587
202009 -1.307 260.280 -1.677
202012 -1.652 260.474 -2.118
202103 -0.865 264.877 -1.091
202106 -0.697 271.696 -0.857
202109 -0.723 274.310 -0.880
202112 -0.788 278.802 -0.944
202203 -0.481 287.504 -0.559
202206 -0.880 296.311 -0.992
202209 -3.384 296.808 -3.807
202212 -0.349 296.797 -0.393
202303 0.075 301.836 0.083
202306 0.037 305.109 0.040
202309 -0.131 307.789 -0.142
202312 0.183 306.746 0.199
202403 0.147 312.332 0.157
202406 0.511 314.175 0.543
202409 0.342 315.301 0.362
202412 0.306 315.605 0.324
202503 0.055 319.799 0.057
202506 -0.121 322.561 -0.125
202509 0.026 324.800 0.027
202512 0.700 324.054 0.721
202603 0.026 330.213 0.026
202606 0.009 333.952 0.009

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-4.37 mean?
Interpace Biosciences (STU:PF42) has a E10 of €-4.37 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Interpace Biosciences and its competitors.
Is Interpace Biosciences' E10 too high?
Interpace Biosciences' current E10 is €-4.37. Overall, Interpace Biosciences has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Interpace Biosciences' E10 compare to PRPO and ADVB?
Interpace Biosciences' E10 of €-4.37 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Interpace Biosciences and its competitors. Interpace Biosciences's current E10 is €-4.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Interpace Biosciences stock overvalued right now?
Interpace Biosciences (STU:PF42) has a current E10 of €-4.37. The stock's GF Value™ is €0.17, compared to a current price of €1.34 — trading 688.2% above its estimated fair value. The current E10 is €-4.37. Interpace Biosciences' overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Interpace Biosciences (STU:PF42), the current E10 is €-4.37 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Interpace Biosciences (STU:PF42) Overvalued in 2026?

Based on GuruFocus' analysis, Interpace Biosciences stock appears to be overvalued. The current stock price of €1.34 is trading 688.2% above its estimated GF Value™ of €0.17.

Key valuation signals for STU:PF42:

  • E10: €-4.37
  • GF Value™: €0.17 vs. price of €1.34 (688.2% above fair value)
  • GF Score™: 41/100 with 5 warning signs

No single metric tells the full story. See the STU:PF42 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Interpace Biosciences Business Description

Other Exchanges IDXG:USA
Address 2001 Route 46, Suite 310, Waterview Plaza, Parsippany, NJ, USA, 07054
Interpace Biosciences Inc provides esoteric molecular diagnostic testing and pathology services to aid physicians in evaluating cancer risk in patients with indeterminate biopsies and a perceived high risk of cancer based on clinical features. The company develops and commercializes genomic tests and related first-line assays that can personalize medicine and help improve patient diagnosis and management. Its clinical customers mainly consist of physicians, hospitals, cancer centers, commercial laboratories, pathology groups, and clinics. The various diagnostic tests offered by the company include ThyGeNEXT and ThyraMIRv2 for the detection of thyroid cancer.
41GF Score

Get the complete analysis for STU:PF42

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.34
Price
€0.17
GF Value